"That's not science. That's ideology." -- Gregory Poland, MD, president of the Atria Health and Research Institute in New ...

The Trump administration is discussing plans to dismantle the CDC's Division on HIV Prevention, something the Frannie Peabody ...

The United Nations AIDS agency has warned that the number of new HIV infections worldwide could surge to 2,000 per day, with ...

The White Lotus is still going strong. It's one of the best shows on Max, and season three is picking up steam as it enters ...

People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

GILD boasts a market-leading portfolio of HIV treatments both for treating the disease and prevention. The company has two drugs for HIV prevention in its portfolio, Descovy and Truvada.

Gilead Sciences takes a hit after a Wall Street Journal reports state that the Trump administration is looking to slash ...

Why: The stock's decline follows a report from The Wall Street Journal that the US Health and Human Services Department is considering drastic cuts to federal funding for HIV prevention in the US.

In January, the White House ordered an immediate halt to the distribution of HIV medications by U.S.-funded foreign clinics, ...

The Trump administration is planning to make cost-saving cuts by merging two similar HIV/AIDS prevention programs run by the Centers for Disease Control and Prevention (CDC) and Health Resources ...